Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.695 USD | -2.59% | +0.64% | -27.58% |
Apr. 10 | Terns Pharmaceuticals, Inc. Appoints Melita Sun Jung as Chief Business Officer | CI |
Mar. 27 | UBS Trims Terns Pharmaceuticals Price Target to $18 From $19, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.58% | 312M | |
+3.25% | 42.11B | |
+48.83% | 40.08B | |
+8.47% | 40B | |
-10.82% | 26.87B | |
+8.16% | 24.58B | |
-23.21% | 18.44B | |
+1.16% | 11.94B | |
+33.51% | 11.66B | |
+7.07% | 11.01B |
- Stock Market
- Equities
- TERN Stock
- News Terns Pharmaceuticals, Inc.
- Terns Pharmaceuticals : Completes Patient Enrollment in Part 1 of Phase 1b Trial of Potential Treatment for Non-Alcoholic Steatohepatitis